Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)
NCT01711684
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Neoplasm Metastasis
Melanoma
Interventions
DRUG:
Diphenylcyclopropenone (DPCP)
Sponsor
Rockefeller University